Search results

• Finished

  STTR: A Pilot Pharmacokinetic and Local Tolerability Study

  Adams, V. (PI), Archer, S. (CoI), Davis, G. (CoI) & Martin, C. (CoI)

  Alcomed Incorporated

  5/1/12 → 2/28/13

  Project: Research project

• A Pharmacokinetic/Pharmacodynamic Study of Oral Bexarotene with Cisplatin and Irinotecan in Extensive Stage Small Cell Lung Cancer

  Davis, G. (PI) & Adams, V. (CoI)

  Ligand Pharmaceuticals Inc

  9/1/04 → 4/30/05

  Project: Research project

• A Single-Dose, Randomized, Two-Period Crossover Pharmacokinetic Study of 2.0 mg Intranasal Hydromorphone Hydochloride in Healthy Volunteers Using 10 mg/ml and 20 mg/ml Formulations

  Davis, G. (PI) & Archer, S. (CoI)

  Intranasal Technology Inc

  10/1/01 → 6/30/02

  Project: Research project

• A Randomized Single and Multiple Dose Pharmacokinetic Study of 1.0 mg or 2.0 mg Intranasal Butophanol Tartrate in Healthy Volunteers

  Davis, G. (PI) & Archer, S. (CoI)

  Intranasal Technology Inc

  8/1/01 → 6/30/02

  Project: Research project

• Dosing and Safety Trials Using Cyclosporin in Severe Head Injury

  Young, A. (PI), Hatton-Kolpek, J. (CoI), Kryscio, R. (CoI), McNamara, P. (CoI) & Davis, G. (Former CoI)

  National Institute of Neurological Disorders & Stroke

  6/1/01 → 5/31/05

  Project: Research project

  • Ciclosporin 100%
  • Head Injury 100%
  • Pharmacodynamics 37%
  • Pharmacokinetics 37%
  • Clinical Trial 25%

• Protocol EFG 10002 A Double Blind, Placebo Controlled Parallel Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Oral GW572016 Doses in Healthy Subjects

  Adams, V. (PI), DOUKAS, M. (CoI), Davis, G. (CoI), DeSimone, P. (CoI) & Wermeling, D. (CoI)

  Glaxo Wellcome

  6/1/01 → 5/31/02

  Project: Research project

• BT0002--A Single-Dose, Open Label, Randomized, Three-Way Crossover, Bioavailability Study of 1.0 and 2.0 mg Intranasal Butorphanol Tartrate Compared to 2.0 mg Intravenous Butophanol Tartrate in Health Young Volunteers

  Davis, G. (PI)

  Inhalation Technology Inc

  12/15/00 → 2/28/02

  Project: Research project

• A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Study to Access the Safety, Pharmacokinetics, and Pharmacodynamics of ICA-17043 in Patients with Sickle Cell Disease who are in the Steady, Non-Crisis State

  Davis, G. (PI)

  ICAgen Inc

  12/11/00 → 2/28/02

  Project: Research project

• Absolute Bioavailability of Intranasal Hydromorphone HCl in Patients with Perennial or Seasonal Allergic Rhinitis and with Perennial or Seasonal Allergic Rhinitis Treated with Flonase (HM0011)

  McNamara, P. (PI) & Davis, G. (CoI)

  Inhalation Technology Inc

  7/1/00 → 2/28/02

  Project: Research project

• Absolute Bioavailability of Intranasal HCl in Patients with Rhinitis and Rhinitis Treated with Oxymetazoline (HM9905)

  McNamara, P. (PI) & Davis, G. (CoI)

  Inhalation Technology Inc

  7/1/00 → 2/28/02

  Project: Research project